GeneEd Inc. Release: Major Pharmaceutical Companies Maximize Human Performance By Embracing Scientific e-Learning Enterprise-Wide
10/19/2005 5:12:13 PM
Major pharmaceutical companies continue to adopt scientific e-learning across various divisions of the enterprise, ranging from research and development, clinical trials, manufacturing, regulatory and compliance to sales training and physician and patient education, according to a new analysis by GeneEd, Inc. The company, the leading provider of e-learning solutions to the pharmaceutical industry, today announced that it has entered into major e-learning agreements with several large biotechnology and pharmaceutical companies, including Hoffman-LaRoche, Organon Corp., Novo Nordisk and numerous others. The range of pharmaceutical e-learning includes regulatory and compliance training (GxPs, safety, adverse events, pharmacovigilance), pharmaceutical sales force therapeutic area and disease-state training, manufacturing training for pharmaceutical manufacturing staff involved in product scale-up and commercialization, physician product education (GeneEd is a CME category 1 accredited and approved organization) and patient education and outreach. Learner populations range from 3000 manufacturing personnel at a biopharmaceutical to nearly 40,000 people in clinical R&D at a major multi-national pharmaceutical enterprise.